EUROCHIP 3

WP1Status of the project

17 September 2010Sofia, Bulgaria

EUROCHIP-3 PLANEUROCHIP-3 PLAN

Ahti AnttilaAdherence to cervical screening in 5 Eastern EU countries

Renée OtterPopulation-based CR indicators: dissemination and promotion

Piret Veerus Cancer rehabilitation indicators

Andrea Micheli Cutting costs of cancer control

4 MAIN WORK PACKAGES4 MAIN WORK PACKAGES

+ 3 HORIZONTAL WORK PACKAGES+ 3 HORIZONTAL WORK PACKAGEScoordination (A. Micheli), coordination (A. Micheli),

evaluation (Z. Valerianova), evaluation (Z. Valerianova), dissemination (A. Costa)dissemination (A. Costa)

Steering CommitteeSteering Committee

Working TeamWorking Team WP-Coordination

EUROCHIP-3EUROCHIP-3: ORGANISATION CHANGES: ORGANISATION CHANGES

WP-Evaluation

WPScreenin

g

WPRegistratio

n

WPRehabilitatio

n

WPCosts

DGSDGS

DGSDGS

NGSNGS

WP-Dissemination

Panel of ExpertsPanel of Experts

NGSNGS

NGSNGS

NGSNGS

WP: Work packageNGS: National Group of SpecialistsDGS: Domain Group of Specialists (European coverage)

DGSDGS

DGSDGS

NGSNGS

WP1 deliverables

• Administration and management • Preparation of material for the EUROCHIP

website dissemination• Interim reports to the EC at month 18• Final report sent to EC at month 38• Specific reports to be prepared for the European

Commission and/or for the Network of Competent Authorities on specific issues discussed in the EUROCHIP forum

INIT

IAL

INIT

IAL

PROJECT

PROJECT

Date Place Aims

26/09/2008 Tallinn EUROCHIP-3 WP-4 and WP-6 activity coordination

31/10/2008 Milan EUROCHIP-3 Steering Committee meeting

20/01/2009 Sofia EUROCHIP-3 WP-4 activity discussion

10/03/2009 Amsterdam EUROCHIP-3 WP-5 activity discussion

19/03/2009 Bruxelles “European Partnership Action Against Cancer”29/05/2009 Costantia EUROCHIP-3 WP-4 dissemination

06/08/2009 Phone call EUROCHIP-3 WP-2 activity coordination

29/09/2009 Bruxelles “European Partnership Action Against Cancer”26/10/2009 Phone call Discussion on Cernobbio’s meeting with WP-2

08-11/11/09 Cernobbio 3rd International Cancer Control Congress

08/11/2009 Cernobbio EUROCHIP-3 WP-4 and WP-2 coordination

11/11/2009 Cernobbio EUROCHIP-3 WP-6 activity discussion

08/12/2009 Bruxelles “European Partnership Action Against Cancer”

28/01/2010 Luxembourg “European Partnership Action Against Cancer”16/03/2010 Rome EUROCHIP-3 WP-7 activity discussion

INTERIM

INTERIM

REPORT

REPORTWP1 activities

WP2 deliverables

• Dissemination throughout EUROCHIP website

• Monograph and/or series of papers in scientific journals on EUROCHIP3 result

• News flash can be disseminated in 5 Eastern European MS for WP4 activities

• Panel of Experts meeting to disseminate EUROCHIP3 results to the EUROCHIP network

INIT

IAL

INIT

IAL

PROJECT

PROJECT

In short, we propose

• Two or three Cancer World articles• Five media packs tailored to each

country• One media training day for everyone• A guide to working with the media in

cervical cancer screening• Advice and help with specific

dissemination projects

AFTER THE

AFTER THE

INTERIM

INTERIM

REPORT

REPORT

Press packs

• Aim to inform journalists and stimulate them to pose relevant questions to the relevant people

• Present key information, graphs and images

• Published electronically in the local language/languages

Media training day

A hands-on training day for WP4 participants

• Which media for which target audiences?

• Getting their attention: writing press releases, finding news ‘hooks’, organising press events

• Clarifying key messages targeted at the audience

• Delivering the message: conducting press, radio and TV interviews

• Building long-term relationships

CLUJ IN

CLUJ IN

JANUARY

JANUARY

WP4 deliverables

• Publication of EUROCHIP-2 study results

• Study protocol on adherence to cervical screening in 5 Eastern EU MS

• Result of studies on adherence to cervical screening in 5 Eastern EU MS

• WP4 to be strictly connected with WP2 on dissemination

INIT

IAL

INIT

IAL

PROJECT

PROJECT

TUMORI ISSUE

TUMORI ISSUE

SUMMARY - BULGARIA

• National campaign (related with EUROCHIP-3 adherence study) not yet started

• Without this campaign study should be rewiewed

• We suggest

• To prepare an alternative protocol for 15th August

• To share it with EUROCHIP (Ahti/Milan group) but also with your Bulgarian partners because probably this will have organizational and economic implications (about EUROCHIP funds)

• If the campaign will not start before 15th September the EUROCHIP study will follow the new protocol

WARSAW

WARSAW

MEETIN

G

MEETIN

G

NEW PROTOCOL

NEW PROTOCOL

SUMMARY - LATVIA

• Study designed to reach doctors

• Today after meeting discussion with Paolo on destination of 17600 euro available in EUROCHIP

• Data collection closure for April 2011

• Analysis closure for August 2011

WARSAW

WARSAW

MEETIN

G

MEETIN

G

SUMMARY - ESTONIA

• Study started

• All questionnaire sent

• Up to now 26% of respondent

• Project in time for reporting results to EUROCHIP and to ESO

AMENDMENT

AMENDMENT

REQUESTED

REQUESTED

SUMMARY - LITHUANIA

• Study designed aimed to evaluate the role of centralized invitation system

• Is realistic that deadline of analysis is september 2011? YES

• Discussion after meeting with Paolo on the destination of 17600 euro availble in EUROCHIP

WARSAW

WARSAW

MEETIN

G

MEETIN

G

SUMMARY - ROMANIA

• To evaluate the possibility to perform a study

• Ahti will call Florian

AMENDMENT

AMENDMENT

REQUESTED

REQUESTED

DECIDED TO

DECIDED TO

CONTINUE

CONTINUE

WP5 deliverables

• Continuation of CR promotion in countries without CRs

• EUROCHIP qualitative questionnaire

• Report on cancer registry indicators in various countries

• WP5 to be strictly connected with WP2 on dissemination

INIT

IAL

INIT

IAL

PROJECT

PROJECT

Description of WP5• Continuation of population-based CR promotion

o in countries of the EU without PBCRs (Lux, Greece)o Promotion to make the PBCRs national wide in those countries

were only some regions are covered (France, Italy, Spain, Germany..)

• Inventory (Questionnaire) among the PBCRs ono available or collectable (also time delay) EUROCHIP indicatorso whether they are find to be usefulo The linkage possibilities between which databanks (mortality,

hospital discharge…)o Promote the outcomes on different subjects: primary prevention,

screening, clinical items (delay of treatment, treatment according to GLs..)

DURING

DURING

SCSC

Description of WP5

• GreeceA training programme was formed by Mrs Margery Duin, with specific aim to assist in the development of a Cancer Registry (CR) in Greece.

• LuxembourgWP-5 members are in contact with the Ministry of Health in Luxembourg to provide support in the decision making processes necessary for the activation of a National Population based Cancer Registry in Luxembourg

• Qualitative questionnaireQuestionnaire developed in collaboration with ENCR and the EUROCOURSE project. It should be sent to European CRs after interim reports

INTERIM

INTERIM

REPORT

REPORT

EUROCHIP-1 (2000-2002)

Organized more than 20 meetings with participation of more than 120 cancer specialists

a)During these meetings a preliminary list of 158 cancer indicators was progressively discussed up to produce a list of 31 cancer indicators

b)Now some of these indicators are in the ECHI list and should be collected in the same way in all EU countries

c) EUROCHIP-1 cancer indicator list did not include any indicator on cancer rehabilitation

WP6 BackgroundIN

ITIA

L

INIT

IAL

PROJECT

PROJECT

PRIORITY INDICATORS

INCLUSION PRIORITY INDICATOR

PREVALENCE YES HIGH DEFINED

% OF RELAPSE NO

FUNDING FOR REHAB YES HIGH TBD

STRATEGY ON REHAB YES HIGH TBS

GUIDELINE FOR REHAB YES HIGH TBS

FOLLOW-UP NO

NGO DEVOTED TO REHAB

CHANGED MEDIUM TBS

HOMECARE YES HIGH TBS

TRAINING YES HIGH TBD

COUNSELLING CHANGED MEDIUM TBS

RETURN TO WORK NO

QoL YES HIGH TBDTBD: TO BE DEFINED – TBS: TO BE SPECIFIED

WARSAW

WARSAW

MEETIN

G

MEETIN

G

WP7 Deliverables

• List of cancer control items where innovation intervention to reduce costs is possible (for a childhood cancer and female breast cancer).

• Definition of cancer managing actions to cut costs while maintaining outcomes reductions.

• WP7 to be strictly connected with WP2 on dissemination.

INIT

IAL

INIT

IAL

PROJECT

PROJECT